Pfizer Inc. stock underperforms Wednesday when compared to competitors despite daily gains

Shares of Pfizer Inc. PFE rallied 1.71% to $25.58 Wednesday, on what proved to be an all-around poor trading session for the ...
Zacks Investment Research on MSN

Pfizer Inc. (PFE) is attracting investor attention: Here is what you should know

Pfizer (PFE) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...

Pfizer Inc. (NYSE:PFE) is favoured by institutional owners who hold 66% of the company

Every investor in Pfizer Inc. (NYSE:PFE) should be aware of the most powerful shareholder groups. With 66% stake, ...

Pfizer's Stock Just Dropped 6%. Can the Pharmaceutical Giant Bounce Back in 2026?

Despite additional cost savings in 2026, Pfizer also forecasts that its adjusted earnings per share (EPS) will likely decline ...

PFE Market Cap Falls More Than $7B in a Month: How to Play the Stock

Pfizer PFE stock has declined almost 5% in a month, losing $7.3 billion in market capitalization. Shares dipped recently ...

Pfizer: 2026 Guidance Points To Continued Margin And Growth Pressure

Pfizer's 2026 revenue midpoint of $61B and EPS midpoint of $2.90 decline YoY, reflecting persisting headwinds. Read more on ...

UBS likes Pfizer’s MTSR obesity deal but stays neutral on PFE

Pfizer Inc. (NYSE:PFE) is included among the 13 Best Dividend Stocks Paying Over 6%. On January 7, UBS initiated coverage of ...

Pfizer (PFE) Plans Price Increases on About 80 Medicines Despite Broader Pricing Deals

Pfizer Inc. (NYSE:PFE) is included among the 13 Best January Dividend Stocks to Invest in. Pfizer Inc. (NYSE:PFE) is among ...

Pfizer: Why Wall Street Gave Up—And Why That May Be a Mistake

Pfizer enters the new year as a company in transition, but one with a heavily fortified bottom line. Management has set a revenue floor of approximately $61 billion for 2026. This is a realistic, ...